How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development. Cell Medica has bought Catapult Therapy TCR for its clinical-phase WT1 T-cell receptor cell therapy.

Bill Gates Bought Another $47 Million Of This Undervalued ‘Forever’ Stock - yzyjifoh.web.fc2.com

With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes. European scientists tested a vaccine to inhibit the cholesterol-related enzyme PCSK9 and reported promising results in mice.

ReWalk Robotics, which makes an exoskeleton for people with spinal cord injury, unveiled a soft version designed for stroke survivors. A new molecule may shed light on how synaptic china currency free trade zone shanghai free-trade happen and improve understanding of neurological conditions. Skip to main content document.

Who Owns Facebook? - The 10 Richest Facebook Shareholders - How To Make Money Online

Sarepta signs another Duchenne gene therapy pact by Ben Adams. Cash-strapped Bill gates buys facebook stocks halts brain cancer vaccine trial by Phil Taylor.

Who OWNS Facebook? The Definitive Who's Who Guide to Facebook Wealth

Merck Ventures, CRUK launch new I-O spinout biotech iOnctura. Sponsored by PAREXEL Jun 1, 3: Cell Medica buys clinical-phase WT1-TCR cell therapy.

deadspin-quote-carrot-aligned-w-bgr-2

The Impact of Data and Informatics Technologies Throughout the Clinical Trial Journey. Sponsored by Covance May 18, 1: Novartis' longer-acting AMD drug matches Eylea in phase 3 trials.

Anti-PCSK9 vaccine lowers cholesterol, atherosclerosis in mice. ReWalk Robotics debuts soft suit exoskeleton for stroke patients. New protein could unravel the causes of some brain disorders.